Detalhe da pesquisa
1.
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia.
Nat Cancer
; 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38637657